Glypican-3 targeted delivery of 89Zr and 90Y as a theranostic radionuclide platform for hepatocellular carcinoma.
Sci Rep. 2021 Feb 12;11(1):3731. doi: 10.1038/s41598-021-82172-w.
Sci Rep. 2021.
PMID: 33580090
Free PMC article.